Company: CWAN
Filing Date: 2025-02-11
Form Type: S-4
Source: 0001193125-25-023759
Chunk: 249

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-02-11
Form: S-4
Chunk 249
---
 of the registration statement on Form S-4of which this Proxy Statement/Prospectus forms a part and (ii) after the date of this Proxy Statement/Prospectus and prior to the date of the Special Meeting (other than information furnished pursuant to Item 2.02 or Item 7.01 of any Current Report on Form 8-K,unless expressly stated otherwise therein). Such documents are considered to be a part of this Proxy Statement/Prospectus, effective as of the date such documents are filed. You can obtain any of these documents from the SEC, through the SEC’s website at the address described above. You can also obtain any of these documents free of charge by requesting them in writing at the following addresses and telephone numbers:

| For Information Regarding Clearwater:                        
 Clearwater Analytics Holdings, Inc.                          
 777 W. Main Street, Suite 900                                
 Boise, ID 83702 (208) 433-1200 Attention: Investor Relations |     | For Information Regarding Clearwater:                          
 Enfusion, Inc.                                                 
 125 South Clark Street, Suite 750                              
 Chicago, IL 60603 (312) 253-9800 Attention: Investor Relations |

In the event of conflicting information in this Proxy Statement/Prospectus in comparison to any document incorporated by reference into this Proxy Statement/Prospectus, or among documents incorporated by reference, the information in the latest filed document controls. You should rely only on the information contained or incorporated by reference into this Proxy Statement/Prospectus. No one has been authorized to provide you with information that is different from that contained in, or incorporated by reference into, this Proxy Statement/Prospectus. This Proxy Statement/Prospectus is dated , 2025. You should not assume that the information contained in this Proxy Statement/Prospectus is accurate as of any date other than that date. You should not assume that the information incorporated by reference into this Proxy Statement/Prospectus is accurate as of any date other than the date of such incorporated document. Neither Enfusion’s mailing of this Proxy Statement/Prospectus to Enfusion Stockholders nor the issuance by Clearwater of Clearwater Common Stock in the Merger will create any implication to the contrary. This document contains a description of the representations and warranties that each of Clearwater, Acquirer, Merger Sub, Merger Sub II and Enfusion made in the Merger Agreement. Representations and warranties made by Clearwater, Enfusion and other applicable parties are also